Here’s Why Roche Might Buy Watertown’s Tetraphase — And Why Cubist Pharmaceuticals, Inc. Probably Won’t

On Monday, Bloomberg cited unnamed sources in reporting that antibiotics developer Tetraphase is considering a sale to one of two Swiss drug giants. My first thought was: If the small Watertown biotech is going to be sold, why wouldn’t it be the the largest company focused on anti-bacterial drugs in the world, which also just happens to be about seven miles to the north?

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC